Dr. John Maris Receives QED Award to Develop Novel Treatment for Neuroblastoma Published on Feb 07, 2019 in CHOP News A CHOP research leader received an award from the University City Science Center to help develop a new T-cell based treatment for a childhood cancer.
UAE’s Ministry of Health and Prevention Highlights CHOP's Breakthroughs at Arab Health 2019 CHOP, a global leader in pediatric healthcare, exhibited some of its leading medical breakthroughs at the annual Arab Health Exhibition and Congress in Dubai. Read more
Immunotherapy: What’s Next for CAR-T Therapy Published on Jan 24, 2019 in Oncology Update, Cancer Connections Trials of more game-changing cell therapies for pediatric cancer and other diseases are underway or on the horizon at Children's Hospital of Philadelphia.
Peter Kurre, MD, Appointed Director of the Comprehensive Bone Marrow Failure Center Published on Jan 18, 2019 in CHOP News Dr. Kurre will lead a world-renowned, multidisciplinary team in developing new therapies for BMF syndromes and in basic research.
Humanized CD19: CAR-T Immunotherapy for First Relapse of ALL in Down Syndrome Patient Published on Jan 11, 2019 in Cancer Connections An alternative, humanized CD19 CAR T product for first relapse of pediatric ALL is being evaluated in a clinical trial at Children's Hospital of Philadelphia.
Proton Therapy for Craniopharyngioma Published on Jan 10, 2019 in Cancer Connections Proton therapy at CHOP helped Elena regain her vision and remain free of craniopharyngioma two years after treatment.
Pediatric Brain Tumors: Advances in Low-grade Glioma Care and Research Published on Jan 10, 2019 in Cancer Connections Learn about CHOP's goal to develop improved, less toxic therapies for pediatric brain tumors by integrating neuro-oncology, neurosurgery, research and big data.
Children’s Hospital of Philadelphia Announces Endowed Chair in Pediatric Neuroblastoma Research Published on Dec 14, 2018 in CHOP News CHOP recipient, physician-scientist Dr. Yael Mossé, is innovating targeted, less toxic therapies for cancer affecting mostly infants and young children.
CAR T-cell Therapy Hailed as Transformative in Pediatric Medicine Published on Dec 05, 2018 in CHOP News CHOP’s clinical and research teams aggressively pursue options in the field of personalized, cellular gene therapies.
CHOP Scientists Report How Some Cancer Cells Develop Resistance to CAR T-cell Therapy Published on Nov 27, 2018 in CHOP News, Cancer Connections CHOP researchers analyze how some cancer cells resist a groundbreaking cellular therapy, and have found clues to overcoming that resistance.